The Food and Drug Administration authorized newly modified Covid-19 booster shots to target the latest versions of the Omicron variant. The authorization, however, comes without a key part of the decision-making process.

WSJ’s Daniela Hernandez explains what’s changed with these new booster shots.

Photo: Laura Kammermann

0:00 The FDA has just authorized new Covid-19 booster shots targeting Omicron subvariants
0:26 These new shots haven’t completed human clinical trials
1:04 New omicron boosters vs. original covid vaccines
1:34 Concerns about the omicron booster shots
2:12 How will the new boosters be rolled out, and who is eligible?
2:45 Government distribution challenges

I’m Daniela Hernandez, a health and science reporter for WSJ, and on this channel I’ll be covering a variety of subjects from neuroscience to the science of food and public health. If you’re interested in science and health and how cutting edge research impacts our lives, don’t forget to subscribe.

#Omicron #Booster #DanielaHernandez

свернуть